Colorectal Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Colorectal Cancer Cell and Gene Therapy Market Report Overview
The CRC cell and gene therapy market size across the 15MM was $18.9 billion in 2021. The market growth will be attributed to the combination therapy of OVs + ICIs in dMMR/MSI-H patients in 2L and 3L settings.
Colorectal Cancer Cell and Gene Therapy Market Outlook, 2021-2031 ($ Billion)
Buy the Full Report to Know More about the Colorectal Cancer Cell and Gene Therapy Market Forecast
The CRC cell and gene therapy market research report offers a comprehensive insight into the market through 2032. The report provides an overview of the disease including epidemiology, symptoms, diagnosis, disease management, countries where the disease is prevalent, and leading players associated with the market.
Market Size (2021) | $18.9 billion |
Forecast Period | 2021-2031 |
Key Regions | · APAC
· Europe · Middle East · North America |
Leading Players | · Turnstone Biologics Inc
· Alaunos Therapeutics Inc · F. Hoffmann-La Roche Ltd · Immunovative Therapies Ltd · Zhejiang Yangshengtang Biotech Co Ltd |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Colorectal Cancer Cell and Gene Therapy Market Dynamics
OVs are expected to be efficacious only in dMMR/MSI-H patients due to MOA but efficacy has far been lacking. However, Suboptimal survival and a lack of available treatment options for mCRC patients in 3L+ settings will drive CGT usage during the forecast period.
Colorectal Cancer Cell and Gene Therapy Market Analysis by Treatment
Unmet need for mCRC remains high with the greatest unmet need within mCRC being the lack of treatment options for RAS-mutated patients, which make up a large proportion of the total mCRC patient population. Most patients with mCRC experience disease progression or develop resistance to the currently available treatment options. Owing to this, the most clinically valuable way for CGT agents to add value is by demonstrating durable long-term remission,
Buy the Full Report for More Insights into the Colorectal Cancer Cell and Gene Therapy Market Treatment
Colorectal Cancer Cell and Gene Therapy Market Segmentation by Regions
North America had the highest sales in 15MM in the CRC cell and gene therapy market.
A few of the key regions in the market are APAC, Europe, Middle East, and North America.
Colorectal Cancer Cell and Gene Therapy Market Analysis by Regions, 2021 (%)
Buy Full Report for More Regional Insights into the Colorectal Cancer Cell and Gene Therapy Market
Colorectal Cancer Cell and Gene Therapy Market - Competitive Landscape
Cell therapy presents as the most advanced CGT modality, with three ongoing Phase II trials sponsored by Immunovative Therapies, Bristol-Myers Squibb, and ImmunityBio. Unlike in hematological malignancies, approvals based on Phase II data are highly unlikely in CRC, therefore the future players will be better elucidated when Phase III trials have been initiated.
A few of the major players in the colorectal cancer cell and gene therapy market are:
- Turnstone Biologics Inc
- Alaunos Therapeutics Inc
- Hoffmann-La Roche Ltd
- Immunovative Therapies Ltd
- Zhejiang Yangshengtang Biotech Co Ltd
Colorectal Cancer Cell and Gene Therapy Market Analysis by Companies
Buy the Full Report to Know More about Companies in the Colorectal Cancer Cell and Gene Therapy Market
Colorectal Cancer Cell and Gene Therapy Country Outlook (Value, $ Billion, 2021-2031)
- APAC
- Europe
- Middle East
- North America
Scope
This report includes disease epidemiology, a 10-year patient-based forecast for marketed and pipeline therapies with established mechanisms of action, and cell & gene therapies by class, including early- to late clinical-stage pipeline products with launch date assessment by 8MM market.
Key Highlights
- Report deliverables include a PowerPoint report and an Excel-based forecast model.
- Forecast includes 8 countries.
- Forecast covers 2021-2031.
- Seven markets are extrapolated, obtaining a 15-market value for all CRC therapeutics.
Reasons to Buy
- Access cell & gene therapy sales forecasts across multiple regions.
- Gain insight into promising early-stage approaches.
Alaunos Therapeutics
Replimune
Triumvira Immunologics
Table of Contents
Frequently asked questions
-
What was the CRC cell and gene therapy market size across the 8MM in 2021?
The CRC cell and gene therapy market size across the 15MM was valued at $18.9 billion in 2021.
-
Which region had the highest sales in the 8MM CRC cell and gene therapy market?
North America held the highest sales in the CRC cell and gene therapy market across the 8MM in 2021.
-
Who are the leading players operating in the CRC cell and gene therapy market?
A few of the major players in the CRC cell and gene therapy market are Turnstone Biologics Inc, Alaunos Therapeutics Inc, F. Hoffmann-La Roche Ltd, Immunovative Therapies Ltd, Zhejiang Yangshengtang Biotech Co Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.